Hui Wang

机构：Ministry of Education of the People's Republic of China, Zunyi Medical University, Guangdong Pharmaceutical University, Dalian Medical University, Zhengzhou University, Shenyang Anorectal Hospital, Affiliated Hospital of Guizhou Medical University, Hunan Cancer Hospital, Beijing Radiation Center, First Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Zhengzhou University, Affiliated Hospital of Zunyi Medical College · ORCID：0000-0003-0141-4865

发表论文 160 篇 · 总被引 2965 次 · h-index 31

代表论文

• VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO‐1 Signaling Pathway in Diabetic Nephropathy (2023 · Advanced Science · 被引 108)
• Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT ‐1 trial (2023 · Diabetes Obesity and Metabolism · 被引 43)
• T cell exhaustion in human cancers (2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 38)
• Mitochondria‐Associated Endoplasmic Reticulum Membranes in Human Health and Diseases (2025 · MedComm · 被引 31)
• CNPY2 Aggravates Renal Tubular Cell Ferroptosis in Diabetic Nephropathy by Regulating PERK/ATF4/CHAC1 Pathway and MAM Integrity (2025 · Advanced Science · 被引 31)
• Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice (2023 · European Journal of Pharmacology · 被引 19)